Figure 8. Eye dryness and irritation. Loss of temperature and touch sensations in ophthalmic and mouth regions. Condition 5 months post the mRNA vaccination (A). Skin necrosis and purulent exudates probably due to secondary bacterial infection. Remarkable change of skin color, edema and increased vascularity. Preauricular cavitation starting to form with inflammatory exudates. Growing mass on zygomatic region (blue arrow). Condition 13 months post the mRNA vaccination (B).
